More Adverse Event Red Tape from the FDA. Good or Bad?

By |2015-02-03T18:49:01+00:00February 3rd, 2015|Pharma News|

Oh boy, more forms and more signatures and more questions. Just what we need or not? I'm all for open communications and 100% visibility for adverse event reporting, but what exactly is the issue? The FDA is now questioning the scope of AE reporting and claims that almost all submissions are incomplete. Personally, I've read [...]